dual adenosine A2A antagonist/MAO-B inhibitors (Sigma Tau)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual adenosine A2A antagonist/MAO-B inhibitors (Sigma Tau)
Drug Alias NameST-3564
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonistsMonoamine oxidase B inhibitors
TargetsAdenosine A2a receptorMonoamine oxidase B
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSigma-Tau Industrie Farmaceutiche Riunite Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigma-Tau Industrie Farmaceutiche Riunite Spa
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A